We are Orphinic Scientific

We develop first-in-class or best-in-class projects which have potential to become life-changing therapies

Orphinic Scientific focuses on high quality assets in orphan
in line with proven business model of similar development companies.

We focus on therapeutics but also look at diagnostics, medical devices, and e-Health.

Please contact Orphinic for more information about the pipeline

Ambulero is a Miami, US-based biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. Ambulero holds an exclusive license from the University of Miami to develop and commercialize research that was shown to promote vascular repair and regeneration. Orphinic Scientific participates in a global development of Ambulero’s breakthrough gene therapy that has a potential to reduce risk of limb ulcers and amputation in patients affected by vascular diseases. For more information,